z-logo
open-access-imgOpen Access
The Future of Insulin Pump Therapy in India and Developing Countries Resale and Recycle – A New Vision
Publication year - 2019
Publication title -
international journal of diabetes and metabolic disorders
Language(s) - English
Resource type - Journals
ISSN - 2475-5451
DOI - 10.33140/ijdmd.04.03.2
Subject(s) - insulin pump , revenue , demise , depreciation (economics) , medicine , business , type 1 diabetes , diabetes mellitus , economics , economic growth , finance , endocrinology , political science , law , human capital , capital formation , financial capital
Diabetes tsunami has hit India in a very devastating way in last decade. There is no doubt that CSII with Insulin pumpTherapy has proved superior to MDI (multiple Dose Injection) therapy in Type1DM as well as Type2DM patients. Economicshas been a very important issue while advocating the Pump to either patients, type 1 or type 2 Diabetes Mellitus patients.Out of 9 (Nine) patients using Insulin Pumps in our centre GANDHI CLINIC, PUNE, INDIA there are 5 Type 2 patients and4 Type 1DM patients. Two Pumps are deposited at my Clinic due to the sad demise of the Type2DM patients. The relativesof these patients do wish to sell these pumps with some depreciation price i.e. at lower price than the new one. One patient(type2DM) has stopped using the Insulin pump due to the adverse advice from another healthcare provider who also wantsto sell the pump at some discounted price. As per my survey in the Metro city of Pune (INDIA) approximately 700 insulinpumps are sold, out of these at least 5-7% of total pumps are not being used anymore. The unused pumps are at least 50 innumber. Therefore revenue in terms of PUMPS in one region of INDIA is about 70000 US Dollars. Total number of pumpsused in INDIA is 70000-72000 pumps approx. The total unused pumps by the patients could be about 3000 to 5000 pumpsin total and thereby the revenue loss in this resource constrained country could be in millions of Dollars. This scenario isprobably the same scene in many developing countries wherein the healthcare budgets are limited. In INDIA, Insulin PumpTherapy is not yet covered by Insurance policy of the patients. Since the pumps are usually purchased thru pocket expensesor with Loan or selling some assets like land or Gold, the relatives of the patients are not wrong in expecting some financialrecovery after losing the most important thing i.e. the PERSON or even if patient does not want to continue the use of pumpdue to any reason. We do see refurbished cars sold and there are eligible and deserving candidates available who cannotpurchase a new model of the Car. I am sure INDIA is an important market of Diabetes Technology related Products likeInsulin Pump, similar to the many developing countries. This article is aimed at KOLs in Dialectology and Economists inthe world for a basic policy change in favour of the patient care.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here